Particle.news

Download on the App Store

Researchers Identify Lithium Deficiency as Alzheimer’s Cause and Reverse Pathology in Mice

Lithium measurement is proposed as an early Alzheimer’s screening tool to pave the way for controlled clinical trials

Image
Image
Image
Image

Overview

  • A Nature paper published August 5 reports that a natural drop in brain lithium levels may trigger Alzheimer’s pathology
  • Mice on lithium-restricted diets developed accelerated amyloid and tau abnormalities while low-dose lithium orotate treatment both prevented and reversed memory loss
  • Postmortem analysis of human brain and blood samples showed significantly lower lithium concentrations in individuals with mild cognitive impairment than in healthy controls
  • Authors advocate measuring serum and brain lithium to detect Alzheimer’s risk at its earliest stages and recommend rigorous human trials to validate the findings
  • Researchers caution against unsupervised lithium supplementation and note that effective dosing and safety must be confirmed in clinical studies despite lithium’s established psychiatric use